Chronic Insomnia Study Investigates Link to Early Dementia Markers in CSF

Historically, insomnia and other sleep disturbances were often viewed as consequences of dementia, resulting from progressive neuronal damage. However, a growing body of evidence suggests a bidirectional relationship, where sleep disturbance might increase vulnerability to dementia. Longitudinal studies have observed that poor sleep often precedes and elevates the risk for dementia by several years, highlighting a critical knowledge gap regarding the direct biological link between chronic insomnia and early dementia markers.

This study's primary objective was to examine the relationship between chronic insomnia and dementia biomarkers (proteins indicative of neurodegeneration, such as amyloid-beta and tau) and orexin levels (a neuropeptide involved in wakefulness and sleep-wake regulation) found in cerebrospinal fluid (CSF). While the abstract describes the study's design and objectives, it does not provide specific results or data from the completed study. The researchers aimed to determine if individuals with chronic insomnia would exhibit different levels of these CSF markers compared to good sleepers, potentially indicating early neurobiological changes associated with dementia risk. The enrollment for the study was 30 participants, with 15 in each group. The study was designed to investigate whether chronic insomnia is associated with altered levels of dementia biomarkers and orexin in the cerebrospinal fluid of middle-aged adults.